Drug Fix: New Complete Response Letter, DTC Ad Regulations And A Potential US FDA Reorg

Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs consider the implications of potential regulations that would cement the FDA’s presumption that it can release complete response letters (:49) and effectively ban direct-to-consumer advertising (18:45), as well as a potential reorganization to create a senior FDA position in charge of all medical products (29:23).

More On These Topics From The Pink Sheet

US FDA To Clarify, Expand ‘Significant Discretion’ To Publish CRLs: insights.citeline.com/pink-sheet/product-revie…

US FDA Moves To Eliminate ‘Adequate Provision’ For DTC Broadcast Ads: insights.citeline.com/pink-sheet/compliance/ma…

HHS Considering US FDA Reorganization With Medical Products Chief Overseeing Centers: insights.citeline.com/pink-sheet/agency-leader…